Varying safety of add-on second-line T2DM treatments
(HealthDay)—For patients with type 2 diabetes who are taking metformin, the risk of cardiovascular events and mortality varies with the addition of different second-line therapies, according to a study published online ...
Jun 17, 2016
0
3